维普期刊资源整合服务平台（V6.5）

28篇 您的检索式：作者名="Milowsky M"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Active chemotherapy for sarcomatoid and progressing renal cell carcinoma 显示文摘	NANUS D M GARINO A MILOWSKY M I	2004	Cancer2004，101，7：	1
2	Phase II study of sunitinib in patients with metastatic urothelial canc- er显示文摘	Gallagher D J Milowsky M I Gerst S R	2010	J Clin Oncol2010，28，8：	1
3	A phase I trial of sorafenib plus gemcitabine and capecitabine for patients with advanced renal cell carcinoma: New York Cancer Consortium Trial NCI 6981显示文摘	Tagawa S T Milowsky M I Jeske S	2011	Am J Clin On- col2011，34，5：	1
4	Active chemotherapy for sarcomatoid and rapidly progressing renal cell carcinoma显示文摘	Nanus D M Garino A Milowsky M I	2004	Cancer2004，101，7：	1
5	Phase II study of lutetium-177-1abeled anti-prostate- specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancer 显示文摘	TAGAWA S T MILOWSKY M I MORRIS M	2013	Clin Cancer Res2013，19，18：	1
6	Low incidence of peri-operative chemotherapy for stage III bladder cancer1998to2003:a report f rom the National Cancer Base显示文摘	David K A Milowsky M l Ritchey J	2007	J Urol2007，178，2：	1
7	Active chemotherapy for collecting duct carcinoma of the kidney:a case report and review of the literature显示文摘	MILOWSKY M I ROSMARIN A TICKOO S K	2002	Cancer2002，94，1：	1
8	Vascular targeted therapy with anti-prostate-specific membrane antigen monoclonal antibody 1591 in advanced solid tumors显示文摘	Milowsky M 1 Nanus D M Kostakoglu L Sheehan C E Vallabhajosula S Goldsmith S 1	2007	J Clin Oncol2007，25，：	1
9	Low inci- dence of perioperative chemotherapy for stage III blad- der cancer 1998 to 2003: a report from the National Cancer Data Base显示文摘	David K A Milowsky M I Ritchey J	2007	J Urol2007，178，2：	1
10	Active chemotherapy for collecting duct carcinoma of the kidney: a case report and review of the literature显示文摘	Milowsky M I Rosmarin A Tickoo S K	2002	Cancer2002，94，1：	1
11	Clinical use of monoclonal antibody HuJ591 therapy:targeting prostate specific membrane antigen显示文摘	Nanus D M Milowsky M I Kostakoglu L	2003	J Urol2003，170，6：	1
12	Phase I trial of 177lutetium-labeled J591,a monoclonal antibody to prostate-specific membrane antigen,in patients with androgenindependent prostate cancer显示文摘	Bander N H Milowsky M I Nanus D M	2005	J Clin Oncol2005，23，21：	1
13	Surveillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000显示文摘	DAVID K A MALLIN K MILOWSKY M I	2009	Cancer2009，115，7：	1
14	Phase I trial of 177 lutetium labeled J591, a monoclonal antibody to prostate-specific membrane antigen, in patients with androgen-independent prostate cancer显示文摘	Bander N H Milowsky M J Nanus D M	2005	J Clin Oncol2005，23，：	1
15	Neutral endopeptidase inhibits neuropeptide-mediated transactivation of the insulin-like growth factor receptor Akt cell survival pathway 显示文摘	Sumitomo M Milowsky MI Shen R	2001	Cancer Res2001，61，8：	1
16	Neutral endopeptidase inhibits neuropeptide-mediated transaectivation of the insulin-like growth factor receptor-Akt cell survival pathway显示文摘	Sumitomo M Milowsky M I Shen R	2001	Cancer Res2001，61，：	1
17	Detection of circulating tumor cells in patients with urothelial cancer显示文摘	Gallagher D J Milowsky M I Ishill N	2009	Ann Oncol2009，20，2：	1
18	Germline BRCA mutation does not prevent response to taxane-based therapy for the treatment of castration-resistant prostate cancer显示文摘	Gallagher D J Cronin A M Milowsky M I		0，，05：	1
19	Genome sequencing identifies a basis foreverolimus sensitivity 显示文摘	IYER G HANRAHAN A J MILOWSKY M I etal	2012	Science2012，338，6104：	1
20	Phase Ⅰ/Ⅱ trial of the prostate-specific membrane antigen (PSMA)-targeted immunoconjugate MLN2704 in patients (pts) with progressive metastatic castration resistant prostate cancer (CRPC) 显示文摘	Milowsky MI Galsky M George D J	2006	J Clin Oncol2006，24，18：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示